Literature DB >> 15075443

The S-adenosyl homocysteine hydrolase inhibitor 3-deaza-adenosine prevents oxidative damage and cognitive impairment following folate and vitamin E deprivation in a murine model of age-related, oxidative stress-induced neurodegeneration.

Thomas B Shea1, David Ashline, Daniela Ortiz, Shelia Milhalik, Eugene Rogers.   

Abstract

Deficiencies in folate promote neurodegeneration and potentiate the influence of other risk factors for neurodegeneration. This is accomplished at least in part by increasing levels of the neurotoxin homocysteine (HC). The S-adenosyl homocysteine (SAH) hydrolase inhibitor 3-deaza-adenosine (DZA) prevents HC accumulation following folate deprivation. We tested the ability of dietary supplementation with DZA to counteract the deleterious influence of folate deprivation. Folate deficiency has previously been shown to potentiate the impact of apolipoprotein E (ApoE); ApoE-/- mice deprived of folate demonstrated increased oxidative damage in brain tissue and impaired cognitive performance as compared to normal mice or to ApoE-/- mice receiving folate. Herein, we demonstrate that dietary supplementation with DZA prevented both the increase in oxidative damage and impaired cognition characteristic of ApoE-/- mice following folate deprivation. These findings suggest that manipulation of the methionine cycle by DZA can counteract folate deficiency. Because folate deprivation, increased HC, and apolipoprotein E deficiency are all risk factors for Alzheimer's disease, these findings also underscore that DZA might be useful in a therapeutic approach to delay neurodegeneration in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15075443     DOI: 10.1385/NMM:5:2:171

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  61 in total

Review 1.  The neurobiological basis of spontaneous alternation.

Authors:  Robert Lalonde
Journal:  Neurosci Biobehav Rev       Date:  2002-01       Impact factor: 8.989

2.  Rapid appearance of hypomethylated DNA in livers of rats fed cancer-promoting, methyl-deficient diets.

Authors:  E Wainfan; M Dizik; M Stender; J K Christman
Journal:  Cancer Res       Date:  1989-08-01       Impact factor: 12.701

3.  Imidazo[4,5-c]pyridines (3-deazapurines) and their nucleosides as immunosuppressive and antiinflammatory agents.

Authors:  T A Krenitsky; J L Rideout; E Y Chao; G W Koszalka; F Gurney; R C Crouch; N K Cohn; G Wolberg; R Vinegar
Journal:  J Med Chem       Date:  1986-01       Impact factor: 7.446

Review 4.  Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress.

Authors:  D Allan Butterfield; Christopher M Lauderback
Journal:  Free Radic Biol Med       Date:  2002-06-01       Impact factor: 7.376

5.  3-deazaadenosine, a S-adenosylhomocysteine hydrolase inhibitor, has dual effects on NF-kappaB regulation. Inhibition of NF-kappaB transcriptional activity and promotion of IkappaBalpha degradation.

Authors:  S Y Jeong; S G Ahn; J H Lee; H S Kim; J W Kim; H Rhim; S W Jeong; I K Kim
Journal:  J Biol Chem       Date:  1999-07-02       Impact factor: 5.157

6.  Differential gene expression of livers from ApoE deficient mice.

Authors:  G S Huang; S M Yang; M Y Hong; P C Yang; Y C Liu
Journal:  Life Sci       Date:  2000-11-24       Impact factor: 5.037

7.  Vitamin E deficiency does not induce compensatory antioxidant increases in central nervous system tissue of apolipoprotein E-deficient mice.

Authors:  Thomas B Shea; Eugene Rogers; David Ashline; Daniela Ortiz; Nancy Duarte; Thomas O Wilson; Robert J Nicolosi; Min-Shyan Sheu
Journal:  J Alzheimers Dis       Date:  2003-02       Impact factor: 4.472

8.  In vitro and in vivo transport of zidovudine (AZT) across the blood-brain barrier and the effect of transport inhibitors.

Authors:  R Masereeuw; U Jaehde; M W Langemeijer; A G de Boer; D D Breimer
Journal:  Pharm Res       Date:  1994-02       Impact factor: 4.200

9.  Kinetic and catalytic mechanism of HhaI methyltransferase.

Authors:  J C Wu; D V Santi
Journal:  J Biol Chem       Date:  1987-04-05       Impact factor: 5.157

10.  Homocysteine increases the relative number of apoptotic cells and reduces the relative number of apoptotic bodies in HL-60 cells treated with 3-deazaadenosine.

Authors:  P C Endresen; P S Prytz; S Lysne; J Aarbakke
Journal:  J Pharmacol Exp Ther       Date:  1994-06       Impact factor: 4.030

View more
  1 in total

1.  3-Deazaadenosine mitigates arterial remodeling and hypertension in hyperhomocysteinemic mice.

Authors:  Alexander V Ovechkin; Neetu Tyagi; Utpal Sen; David Lominadze; Mesia M Steed; Karni S Moshal; Suresh C Tyagi
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-06-30       Impact factor: 5.464

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.